NCT07194902
HIV Self-testing for Partners of HIV-uninfected Postpartum Women
At risk: Primary completion moved 6 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Aug 28, 2026 to Feb 28, 2027 Show 6 more changesShow less
- Eligibility criteria expanded, about 14 words
- Enrollment closed, study ongoing
- Interventions: HIVST for Partners and PrEP uptake for HIV-uninfected Postpartum Women ("H4P"). (Behavioral) to HIVST for Partners and PrEP uptake for HIV-uninfected Postpartum Women ("H4P"). (Behavioral)
- Secondary endpoints: details revised at 9 of 11 entries
- Site details revised
- Publications: details revised at 1 of 1 entry
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Feb 1, 2026 to Mar 19, 2026
- Site details revised
- Notable Start date: Dec 1, 2025 to Feb 1, 2026
- Primary endpoints revised (5)
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (11)
Show 6 moreShow less
Arms and interventions
At one of their last scheduled antenatal care visits (i.e., between 30- 40 weeks' gestation), all female participants will be provided with up to three HIVST kits for male partner distribution, and will be provided with information and a demonstration per the standard of care (SOC) for HIVST kit distribution. In addition to what female participants in the control arm engage in, they will engage in 30-45 minutes HIVST and PrEP uptake counseling intervention at the baseline visit. Male partners, in addition to the SOC written information provided to the control arm, will also receive a QR code linked to a brief video created by the study team. The video will communicate, among other things, information on geographically diverse HIV treatment resources, and why linkage to HIV care is needed in the context of the relationship (e.g., increased risk for HIV during the postpartum period, risk of transmission to infant during breastfeeding, his role in protecting the family's health).
At one of their last scheduled antenatal care visits (i.e., between 30- 40 weeks' gestation), all female participants will be provided with up to three HIVST kits for male partner distribution, and will receive 15-20 minutes of counseling. Female participants will receive OraQuick Rapid HIV-1/2 Antibody Tests. OraQuick kits will include step-by-step instructions on use and interpretation of results. All female participants will be provided with information and a demonstration per the standard of care (SOC) for HIVST kit distribution and will engage in a brief exercise that involves evaluating the pros and cons of offering HIVST kits to their partners. All men will be provided with the HIVST kit by their female partners (including directions for use, consistent with SOC), along with a letter describing how to contact the study team.
Behavioral: HIVST for Partners and PrEP uptake for HIV-uninfected Postpartum Women ("H4P").
Sites
1 site in 1 country
- Wits MatCH Research UnitDurban, KwaZulu-Natal, South Africa